Por: ABC News Business November 01, 2022
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its vaccine and top third-quarter expectations.The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion so far this year.Sales from the vaccine Comirnaty, meanwhile, tumbled 66% to $4.4 billion in the quarter. That was mainly due to changes in a European Commission supply agreement that... + full article
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
Associated Press USA Health November 02, 2022
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its coronavirus vaccine and top third-quarter expectations.The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion... + más
Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN
Pfizer rides Paxlovid sales to better-than-expected quarter | ABC News
MarketWatch USA Business November 01, 2022
Pfizer’s CFO David Denton cited strong performance from the company’s Paxlovid and Eliquis products, particularly in the U.S., as well as the “continued impressive launch” of the Prevnar 20 vaccine for adults in the U.S. Paxlovid is an antiviral used to treat COVID-19,... + más
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
CNBC USA Health November 01, 2022
In this articleVials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido Reuters on Tuesday raised its 2022 earnings guidance after... + más
CNN USA Health October 14, 2022
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most... + más
Pfizer pledges $120M to produce oral COVID-19 treatment Paxlovid at Michigan factory | New York Daily News
Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11 | MarketWatch
New York Daily News USA Health September 24, 2022
Pfizer is sinking $120 million into a Michigan factory to drastically increase its production and supply of its oral COVID-19 treatment, the pharmaceutical company announced Monday. The investment, which will create more than 250 high-skilled jobs at the Kalamazoo plant, will be... + más
Pfizer agrees to supply millions of Paxlovid courses to Global Fund | The Hill
Supreme Court confirms public can attend hearings in October for first time since Covid lockdown of March 2020 | CNBC
About iurex | Privacy Policy | Disclaimer |